Hereditary ATTR (hATTR) amyloidosis is a serious disease. It is caused by changes in the transthyretin (TTR) gene. This rare genetic disorder affects about 50,000 people globally.
The TTR gene mutation affects how thyroxine and retinol are transported. This can cause the TTR protein to change. This change leads to amyloid deposits in different organs.
Hereditary transthyretin amyloidosis shows up in different ways. Some people mainly have nerve problems. Others have heart issues. Knowing how it develops helps doctors diagnose and treat it better.
Key Takeaways
- Hereditary ATTR amyloidosis is a rare genetic disorder caused by TTR gene mutations.
- The condition affects approximately 50,000 individuals worldwide.
- Mutations in the TTR gene lead to the formation of abnormal TTR protein.
- The disease manifests variably, with neuropathic and cardiac phenotypes.
- Understanding hereditary ATTR amyloidosis is key for effective diagnosis and management.
Understanding Hereditary Amyloidosis: Definition and Prevalence
Hereditary amyloidosis is a rare genetic disorder. It affects many parts of the body and is caused by a faulty gene. This condition is known as hereditary transthyretin-mediated amyloidosis (hATTR). It has a big impact on people’s lives.
What Is Hereditary ATTR Amyloidosis?
Hereditary ATTR amyloidosis happens when the TTR gene mutates. This leads to abnormal protein production. The protein then misfolds and builds up in tissues, causing symptoms.
Medical Expert, an expert in amyloidosis, said,
Global and Regional Prevalence
Worldwide, about 50,000 people live with hATTR amyloidosis. But many cases are not diagnosed. The V30M mutation is common in Portugal, Spain, France, Sweden, and Japan.
| Region | Prevalent Mutation | Estimated Cases |
| Portugal | V30M | 1,000 – 2,000 |
| Sweden | V30M | 500 – 1,000 |
| Japan | V30M | 1,500 – 3,000 |
Clinical Manifestations and Disease Phenotypes
Hereditary ATTR amyloidosis shows different symptoms in different people. Some mainly have nerve problems, while others have heart issues. The mix of symptoms makes diagnosis and treatment hard.
The type of symptoms depends on the TTR mutation and other factors. Early diagnosis is key to managing the disease and improving life quality.
How Hereditary TTR Amyloidosis Develops: The Molecular Mechanism
It’s important to know how hereditary TTR amyloidosis starts. This condition comes from changes in the TTR gene. These changes affect how the body works.
The TTR Gene and Common Mutations
The TTR gene helps make a protein that carries important substances in the blood. But, if the gene mutates, it can make a bad protein. “More than 100 mutations in the TTR gene have been identified as causing hereditary ATTR amyloidosis.” These changes can make the protein fold wrong.
Protein Misfolding and Amyloid Fibril Formation
When the TTR protein folds wrong, it turns into amyloid fibrils. These are hard to dissolve and build up in tissues. Experts say,
This process is complex. It involves the clumping of wrong TTR proteins.
Organ and Tissue Accumulation
The amyloid fibrils harm organs and tissues. They can build up in the heart, nerves, and stomach. “The clinical manifestations of hereditary ATTR amyloidosis can vary widely depending on the organs affected.” Knowing where they build up helps doctors diagnose and treat the disease.
Conclusion
Hereditary transthyretin-mediated amyloidosis (hATTR) is a complex and often misdiagnosed condition. We have explored its definition, prevalence, and the molecular mechanisms that drive its progression. Recent research shows that the genetic risk is higher than thought, affecting about one in 1,000 people in the UK.
Understanding hereditary amyloidosis is key for early diagnosis and effective treatment. The symptoms of this disease vary widely. This makes it important to recognize the different disease phenotypes.
By studying TTR gene mutations, protein misfolding, and amyloid fibril formation, we can better understand transthyretin amyloidosis. As we learn more about hereditary ATTR hATTR amyloidosis, we get closer to better diagnosis and treatment options. By using the latest research in clinical practice, we can offer more targeted and effective care for those affected by this condition.
FAQ
What is hereditary ATTR amyloidosis?
Hereditary ATTR amyloidosis is a disease caused by gene mutations. These mutations lead to abnormal protein production. This protein misfolds and forms harmful clumps in organs, causing damage.
How common is hereditary ATTR amyloidosis globally?
It’s a rare disease found worldwide. Its prevalence varies by region and ethnicity. Some areas have more cases due to specific mutations.
What are the clinical manifestations of hereditary ATTR amyloidosis?
Symptoms vary widely. Some people feel numbness and pain in their hands and feet. Others experience heart problems like failure and irregular heartbeats.
What is the role of the TTR gene in hereditary ATTR amyloidosis?
The TTR gene makes a protein important for transporting certain substances. Mutations in this gene cause the protein to misfold and form harmful clumps.
How do TTR gene mutations lead to amyloid fibril formation?
Mutations in the TTR gene make the protein unstable. It then misfolds and forms harmful clumps. These clumps damage organs and cause symptoms.
What is the impact of hereditary ATTR amyloidosis on organ function?
Amyloid clumps damage organs, mainly nerves and the heart. This leads to symptoms like neuropathy and heart failure.
Are there different types of TTR gene mutations associated with hereditary ATTR amyloidosis?
Yes, many mutations can cause the disease. Some are more common in certain groups. The mutation type affects how the disease presents and progresses.
How does the disease progress in patients with hereditary ATTR amyloidosis?
Progression varies by mutation and affected organs. Generally, symptoms worsen over time without treatment.
References
National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from https://pubmed.ncbi.nlm.nih.nih.gov/23425519/
Departments
Related Videos
Our Doctors
News
